InVite is a Web-based clinical trial that aims to recruit 1,000 people who were diagnosed with metastatic breast cancer and treated with Avastin before December 31, 2011. The study is sponsored by Genentech, which manufactures Avastin, and the trial Web site is hosted by the genetics company 23andMe.Read Full Story
Genentech and 23andMe have partnered to offer a first of its kind observational study to determine whether people would willingly take part in web-based research. Both companies hope the study will show new ways for research to be conducted online.Read Full Story
A group of 50,000 women who have sisters with breast cancer enrolled in this long-term study. The researchers examined environmental and familial risk factors.Read Full Story
For breast cancers of stage 1 and 2, surgical treatment options include mastectomy and breast-conserving surgery, called lumpectomy. Know the pro's and con's of each.Read Full Story
Many complementary treatments have been found to relieve some side effects that occur with breast cancer treatments.Read Full Story
Dr. Linda Bosserman appears on a segment of the American Health Journal and explains why early detection is important when it comes to treating breast cancer.
The Susan Komen Race for the cure was this past week-end here in town. Usually 35-50,000 people show up for the event that winds through the streets of downtown Portland.Read Full Story
A place to share your stories, your experiences, your concerns and your wisdom.View Discussion Group